nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2E1—Dacarbazine—sarcoma	0.176	0.206	CbGbCtD
Isoniazid—CYP2E1—Mitoxantrone—sarcoma	0.136	0.16	CbGbCtD
Isoniazid—CYP1A2—Dacarbazine—sarcoma	0.102	0.119	CbGbCtD
Isoniazid—CYP3A4—Thiotepa—sarcoma	0.096	0.113	CbGbCtD
Isoniazid—CYP2E1—Etoposide—sarcoma	0.0859	0.101	CbGbCtD
Isoniazid—CYP2C8—Etoposide—sarcoma	0.0642	0.0755	CbGbCtD
Isoniazid—CYP1A2—Etoposide—sarcoma	0.0497	0.0584	CbGbCtD
Isoniazid—CYP3A4—Mitoxantrone—sarcoma	0.0413	0.0485	CbGbCtD
Isoniazid—CYP3A4—Vincristine—sarcoma	0.0284	0.0334	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—sarcoma	0.0279	0.0328	CbGbCtD
Isoniazid—CYP3A4—Etoposide—sarcoma	0.026	0.0306	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—sarcoma	0.0178	0.0209	CbGbCtD
Isoniazid—Neurotoxicity—Vincristine—sarcoma	0.00597	0.0399	CcSEcCtD
Isoniazid—Neurotoxicity—Etoposide—sarcoma	0.00484	0.0324	CcSEcCtD
Isoniazid—Metabolic acidosis—Etoposide—sarcoma	0.00475	0.0317	CcSEcCtD
Isoniazid—Eruption—Dactinomycin—sarcoma	0.00421	0.0282	CcSEcCtD
Isoniazid—Memory impairment—Thiotepa—sarcoma	0.00333	0.0223	CcSEcCtD
Isoniazid—Neuritis—Vincristine—sarcoma	0.0031	0.0207	CcSEcCtD
Isoniazid—Optic neuritis—Etoposide—sarcoma	0.00305	0.0204	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Thiotepa—sarcoma	0.00287	0.0192	CcSEcCtD
Isoniazid—Neurotoxicity—Epirubicin—sarcoma	0.00271	0.0181	CcSEcCtD
Isoniazid—Neurotoxicity—Doxorubicin—sarcoma	0.00251	0.0168	CcSEcCtD
Isoniazid—Aplastic anaemia—Dactinomycin—sarcoma	0.00243	0.0163	CcSEcCtD
Isoniazid—Eruption—Epirubicin—sarcoma	0.00171	0.0114	CcSEcCtD
Isoniazid—Optic neuritis—Epirubicin—sarcoma	0.00171	0.0114	CcSEcCtD
Isoniazid—Eruption—Doxorubicin—sarcoma	0.00158	0.0106	CcSEcCtD
Isoniazid—Optic neuritis—Doxorubicin—sarcoma	0.00158	0.0106	CcSEcCtD
Isoniazid—Hyperglycaemia—Thiotepa—sarcoma	0.00148	0.00988	CcSEcCtD
Isoniazid—Jaundice—Thiotepa—sarcoma	0.00142	0.00952	CcSEcCtD
Isoniazid—Neuritis—Epirubicin—sarcoma	0.00141	0.00942	CcSEcCtD
Isoniazid—Agranulocytosis—Thiotepa—sarcoma	0.00136	0.00912	CcSEcCtD
Isoniazid—Agranulocytosis—Dactinomycin—sarcoma	0.00135	0.00905	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—sarcoma	0.0013	0.00871	CcSEcCtD
Isoniazid—Hepatitis—Dactinomycin—sarcoma	0.0013	0.0087	CcSEcCtD
Isoniazid—Hyperglycaemia—Mitoxantrone—sarcoma	0.00128	0.00854	CcSEcCtD
Isoniazid—Neuropathy peripheral—Vincristine—sarcoma	0.00127	0.00849	CcSEcCtD
Isoniazid—Liver injury—Epirubicin—sarcoma	0.00125	0.00836	CcSEcCtD
Isoniazid—Jaundice—Mitoxantrone—sarcoma	0.00123	0.00822	CcSEcCtD
Isoniazid—Agranulocytosis—Mitoxantrone—sarcoma	0.00118	0.00787	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Epirubicin—sarcoma	0.00116	0.00773	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—sarcoma	0.00116	0.00773	CcSEcCtD
Isoniazid—Hepatitis—Mitoxantrone—sarcoma	0.00113	0.00757	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.00107	0.00715	CcSEcCtD
Isoniazid—Hepatocellular injury—Epirubicin—sarcoma	0.00105	0.00703	CcSEcCtD
Isoniazid—Ill-defined disorder—Dactinomycin—sarcoma	0.00105	0.00703	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—sarcoma	0.00103	0.00688	CcSEcCtD
Isoniazid—Jaundice—Etoposide—sarcoma	0.00102	0.00684	CcSEcCtD
Isoniazid—Malaise—Dactinomycin—sarcoma	0.00102	0.00683	CcSEcCtD
Isoniazid—Convulsion—Thiotepa—sarcoma	0.000989	0.00661	CcSEcCtD
Isoniazid—Aplastic anaemia—Epirubicin—sarcoma	0.000987	0.0066	CcSEcCtD
Isoniazid—Agranulocytosis—Etoposide—sarcoma	0.000979	0.00655	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—sarcoma	0.000973	0.00651	CcSEcCtD
Isoniazid—Discomfort—Dactinomycin—sarcoma	0.000953	0.00637	CcSEcCtD
Isoniazid—Ill-defined disorder—Mitoxantrone—sarcoma	0.000915	0.00612	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—sarcoma	0.000913	0.00611	CcSEcCtD
Isoniazid—Thrombocytopenia—Thiotepa—sarcoma	0.000912	0.0061	CcSEcCtD
Isoniazid—Thrombocytopenia—Dactinomycin—sarcoma	0.000905	0.00605	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—sarcoma	0.000895	0.00598	CcSEcCtD
Isoniazid—Malaise—Mitoxantrone—sarcoma	0.000889	0.00595	CcSEcCtD
Isoniazid—Anorexia—Thiotepa—sarcoma	0.000888	0.00594	CcSEcCtD
Isoniazid—Anorexia—Dactinomycin—sarcoma	0.000881	0.00589	CcSEcCtD
Isoniazid—Diabetes mellitus—Epirubicin—sarcoma	0.000877	0.00587	CcSEcCtD
Isoniazid—Convulsion—Vincristine—sarcoma	0.000877	0.00587	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—sarcoma	0.000873	0.00584	CcSEcCtD
Isoniazid—Convulsion—Mitoxantrone—sarcoma	0.000854	0.00571	CcSEcCtD
Isoniazid—Paraesthesia—Thiotepa—sarcoma	0.000837	0.00559	CcSEcCtD
Isoniazid—Discomfort—Mitoxantrone—sarcoma	0.000829	0.00555	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—sarcoma	0.000828	0.00554	CcSEcCtD
Isoniazid—Dyspepsia—Thiotepa—sarcoma	0.00082	0.00548	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—sarcoma	0.000812	0.00543	CcSEcCtD
Isoniazid—Decreased appetite—Thiotepa—sarcoma	0.00081	0.00542	CcSEcCtD
Isoniazid—Thrombocytopenia—Vincristine—sarcoma	0.000809	0.00541	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—sarcoma	0.000808	0.0054	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Thiotepa—sarcoma	0.000804	0.00538	CcSEcCtD
Isoniazid—Decreased appetite—Dactinomycin—sarcoma	0.000804	0.00538	CcSEcCtD
Isoniazid—Fatigue—Thiotepa—sarcoma	0.000803	0.00537	CcSEcCtD
Isoniazid—Fatigue—Dactinomycin—sarcoma	0.000797	0.00533	CcSEcCtD
Isoniazid—Thrombocytopenia—Mitoxantrone—sarcoma	0.000788	0.00527	CcSEcCtD
Isoniazid—Anorexia—Vincristine—sarcoma	0.000787	0.00527	CcSEcCtD
Isoniazid—Feeling abnormal—Thiotepa—sarcoma	0.000768	0.00513	CcSEcCtD
Isoniazid—Anorexia—Mitoxantrone—sarcoma	0.000767	0.00513	CcSEcCtD
Isoniazid—Feeling abnormal—Dactinomycin—sarcoma	0.000762	0.0051	CcSEcCtD
Isoniazid—Ill-defined disorder—Etoposide—sarcoma	0.000761	0.00509	CcSEcCtD
Isoniazid—Paraesthesia—Vincristine—sarcoma	0.000742	0.00496	CcSEcCtD
Isoniazid—Malaise—Etoposide—sarcoma	0.000739	0.00495	CcSEcCtD
Isoniazid—Body temperature increased—Thiotepa—sarcoma	0.000736	0.00493	CcSEcCtD
Isoniazid—Body temperature increased—Dactinomycin—sarcoma	0.000731	0.00489	CcSEcCtD
Isoniazid—Paraesthesia—Mitoxantrone—sarcoma	0.000722	0.00483	CcSEcCtD
Isoniazid—Decreased appetite—Vincristine—sarcoma	0.000718	0.0048	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vincristine—sarcoma	0.000713	0.00477	CcSEcCtD
Isoniazid—Fatigue—Vincristine—sarcoma	0.000712	0.00476	CcSEcCtD
Isoniazid—Convulsion—Etoposide—sarcoma	0.00071	0.00475	CcSEcCtD
Isoniazid—Dyspepsia—Mitoxantrone—sarcoma	0.000708	0.00474	CcSEcCtD
Isoniazid—Decreased appetite—Mitoxantrone—sarcoma	0.000699	0.00468	CcSEcCtD
Isoniazid—Fatigue—Mitoxantrone—sarcoma	0.000694	0.00464	CcSEcCtD
Isoniazid—Discomfort—Etoposide—sarcoma	0.00069	0.00461	CcSEcCtD
Isoniazid—Hypersensitivity—Thiotepa—sarcoma	0.000686	0.00459	CcSEcCtD
Isoniazid—Hypersensitivity—Dactinomycin—sarcoma	0.000681	0.00456	CcSEcCtD
Isoniazid—Asthenia—Thiotepa—sarcoma	0.000668	0.00447	CcSEcCtD
Isoniazid—Asthenia—Dactinomycin—sarcoma	0.000663	0.00444	CcSEcCtD
Isoniazid—Feeling abnormal—Mitoxantrone—sarcoma	0.000663	0.00443	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—sarcoma	0.000655	0.00438	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—sarcoma	0.000653	0.00437	CcSEcCtD
Isoniazid—Body temperature increased—Vincristine—sarcoma	0.000653	0.00437	CcSEcCtD
Isoniazid—Anorexia—Etoposide—sarcoma	0.000638	0.00427	CcSEcCtD
Isoniazid—Body temperature increased—Mitoxantrone—sarcoma	0.000636	0.00425	CcSEcCtD
Isoniazid—Hypersensitivity—Vincristine—sarcoma	0.000609	0.00407	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—sarcoma	0.000604	0.00404	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—sarcoma	0.000601	0.00402	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—sarcoma	0.000595	0.00398	CcSEcCtD
Isoniazid—Hypersensitivity—Mitoxantrone—sarcoma	0.000593	0.00396	CcSEcCtD
Isoniazid—Asthenia—Vincristine—sarcoma	0.000593	0.00396	CcSEcCtD
Isoniazid—Vomiting—Thiotepa—sarcoma	0.000592	0.00396	CcSEcCtD
Isoniazid—Vomiting—Dactinomycin—sarcoma	0.000588	0.00393	CcSEcCtD
Isoniazid—Rash—Thiotepa—sarcoma	0.000587	0.00393	CcSEcCtD
Isoniazid—Rash—Dactinomycin—sarcoma	0.000583	0.0039	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—sarcoma	0.000582	0.00389	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—sarcoma	0.000578	0.00386	CcSEcCtD
Isoniazid—Asthenia—Mitoxantrone—sarcoma	0.000577	0.00386	CcSEcCtD
Isoniazid—Fatigue—Etoposide—sarcoma	0.000577	0.00386	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—sarcoma	0.000577	0.00386	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—sarcoma	0.000573	0.00383	CcSEcCtD
Isoniazid—Nausea—Thiotepa—sarcoma	0.000553	0.0037	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—sarcoma	0.000551	0.00369	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—sarcoma	0.000551	0.00368	CcSEcCtD
Isoniazid—Nausea—Dactinomycin—sarcoma	0.000549	0.00367	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—sarcoma	0.000549	0.00367	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—sarcoma	0.000533	0.00357	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—sarcoma	0.00053	0.00355	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—sarcoma	0.000529	0.00354	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—sarcoma	0.000528	0.00353	CcSEcCtD
Isoniazid—Vomiting—Vincristine—sarcoma	0.000525	0.00351	CcSEcCtD
Isoniazid—Rash—Vincristine—sarcoma	0.000521	0.00348	CcSEcCtD
Isoniazid—Vomiting—Mitoxantrone—sarcoma	0.000512	0.00342	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—sarcoma	0.000508	0.0034	CcSEcCtD
Isoniazid—Rash—Mitoxantrone—sarcoma	0.000507	0.00339	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—sarcoma	0.000493	0.0033	CcSEcCtD
Isoniazid—Nausea—Vincristine—sarcoma	0.000491	0.00328	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—sarcoma	0.000489	0.00327	CcSEcCtD
Isoniazid—Asthenia—Etoposide—sarcoma	0.00048	0.00321	CcSEcCtD
Isoniazid—Nausea—Mitoxantrone—sarcoma	0.000478	0.0032	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—sarcoma	0.000426	0.00285	CcSEcCtD
Isoniazid—Vomiting—Etoposide—sarcoma	0.000426	0.00285	CcSEcCtD
Isoniazid—Rash—Etoposide—sarcoma	0.000422	0.00282	CcSEcCtD
Isoniazid—Malaise—Epirubicin—sarcoma	0.000415	0.00277	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—sarcoma	0.000398	0.00266	CcSEcCtD
Isoniazid—Nausea—Etoposide—sarcoma	0.000398	0.00266	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—sarcoma	0.000395	0.00264	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—sarcoma	0.000387	0.00259	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—sarcoma	0.000384	0.00256	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—sarcoma	0.000368	0.00246	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—sarcoma	0.000367	0.00246	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—sarcoma	0.000358	0.00239	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—sarcoma	0.000358	0.00239	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—sarcoma	0.00034	0.00227	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—sarcoma	0.000337	0.00225	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—sarcoma	0.000331	0.00221	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—sarcoma	0.00033	0.00221	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—sarcoma	0.000326	0.00218	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—sarcoma	0.000324	0.00217	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—sarcoma	0.000323	0.00216	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—sarcoma	0.000312	0.00208	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—sarcoma	0.000309	0.00207	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—sarcoma	0.000306	0.00204	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—sarcoma	0.000302	0.00202	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—sarcoma	0.0003	0.002	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—sarcoma	0.000299	0.002	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—sarcoma	0.000297	0.00198	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—sarcoma	0.000286	0.00191	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—sarcoma	0.000276	0.00185	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—sarcoma	0.000274	0.00184	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—sarcoma	0.000269	0.0018	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—sarcoma	0.000256	0.00171	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—sarcoma	0.000249	0.00167	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—sarcoma	0.000239	0.0016	CcSEcCtD
Isoniazid—Rash—Epirubicin—sarcoma	0.000237	0.00158	CcSEcCtD
Isoniazid—Nausea—Epirubicin—sarcoma	0.000223	0.00149	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—sarcoma	0.000221	0.00148	CcSEcCtD
Isoniazid—Rash—Doxorubicin—sarcoma	0.000219	0.00146	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—sarcoma	0.000206	0.00138	CcSEcCtD
